role interferon therapi melanoma rang potent immunoregulatori molecul cytokin avail therapi human melanoma cytokin interferon ifn great depth therapi melanoma ifn abl host effector cell function tumor cytolyt function lymphocyt monocyt ifn capac distribut immunoregulatori express tumor cell surfac class II product major histocompat locu activ ifn earli applic treatment human melanoma empir evid ifn exert signific anti-tumor effect melanoma statu adjuv trial ifn alpha gamma new indirect host-medi anti-tumor activ ifn opportun meaning anti-tumor activ advanc diseas adjuv set dose rang toxic convent maxim toler hand cooper group eastern cooper oncolog group ecog cancer leukemia group calgb south west oncolog group swog ifn gamma pursuit goal advanc adjuv set melanoma tumor determin clinic role ifn biolog respons modifi equal commit clinic assess immunobiolog mechan anti-tumor effect immunolog assess ifn number cytokin major focu pittsburgh cancer institut region deliveri cytokin appropri toxic approach half-lif region therapi intralesion rout activ rang biolog bacillu calmette-guerin bcg tumor necrosi factor tnf intralymphat therapi methanol extract residu bcg mer-bcg trial progress optim dosag rout like optim role ifn cytokin combin differ biolog modal monoclon antibodi vaccin expans activ desir effector cell popul host enhanc host toxic anti-tumor effect special attent optim sequenc administr therapeut index 